Pharma in Focus
Email Address Sign-Up

Australia's most trusted source of pharma news

Special Report
Aust Covid Vaccine Tracker

Updated 1 February 2021

Overseas regulators have recently opened the gates to two mRNA Covid vaccines with Pfizer's candidate developed in partnership with BioNTech now approved in the US and Europe.

European Union countries including Germany, France, Austria and Italy have said they plan to start vaccinations from December 27 after the European Commission conditionally approved the vaccine, while the first shots have already been administered in the US under an emergency use authorisation.

Looks like you've lost your access to Pharma in Focus. To restore access or update your subscription, click here

Top of the Hill
How not to reform the PBAC
In the face of deep change, is piecemeal enough?
Approvals Action
New registrations for seizures and HIV
Eisai and ViiV add to their core franchises
Special Report
Aust Covid Vaccine Tracker
UPDATE: Distribution of two mRNA vaccines overseas